Trastuzumab-refractory HER2-positive metastatic breast cancer - Use of tanespimycin, a novel Hsp90 inhibitor Article uri icon

Overview

publication date

  • June 1, 2008

Identity

Scopus Document Identifier

  • 73249114287

Additional Document Info

volume

  • 7

issue

  • 6